We are live on
!
Find out more
GL
Graypoint LLC Portfolio holdings
AUM
$1.78B
1-Year Est. Return
16.72%
This Fund
S&P 500
This Quarter
Est. Return
+7%
1 Year Est. Return
+16.72%
3 Year Est. Return
+72.83%
5 Year Est. Return
+113.84%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$97M
(+15%)
Cap. Flow
-$168M
Cap. Flow
% of AUM
-22.26%
Top 10 Holdings %
Top 10 Hldgs %
32.18%
Holding
259
New
29
Increased
109
Reduced
86
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$7.65M |
| 2 |
iShares Core MSCI Europe ETF
IEUR
|
+$4.48M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.38M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$3.32M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$105M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$56.2M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$26.7M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$12.5M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.62% |
| 2 | Financials | 5.89% |
| 3 | Healthcare | 5.01% |
| 4 | Consumer Staples | 3.13% |
| 5 | Communication Services | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Nike
NKE
$64.9B
| $211K | 0.03% |
+1,367
| New | +$184K |
|
252
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $203K | 0.03% |
+3,868
| New | +$202K |
|
253
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$925M
| $191K | 0.03% |
+13,478
| New | +$187K |
|
|
ETB
254
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$452M
| $174K | 0.02% |
10,372
-7,175
| -41% | -$117K |
|
255
Mizuho Financial
MFG
$120B
| $29K | ﹤0.01% |
+10,117
| New | +$30.2K |
|
256
Corbus Pharmaceuticals
CRBP
$167M
| $25K | ﹤0.01% |
+447
| New | +$24.8K |
|
257
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$1.02B
| – | – |
-5,413
| Closed | -$291K |
|
258
JPMorgan Municipal ETF
JMUB
$8.06B
| – | – |
-3,720
| Closed | -$203K |
|
259
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
| – | – |
-16,531
| Closed | -$636K |
|
Similar funds
SVCF
GLA
HIP
MD
WBA
GIM
NRD
NFC
Graypoint LLC's Q2 2021 Portfolio in Review
As of Q2 2021, Graypoint LLC held 259 positions worth $753M, up 15% from $656M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Graypoint LLC withdrew a net $168M in Q2 2021, closing 3 positions and reducing 86 holdings. Its most notable exit was State Street SPDR Portfolio S&P 500 High Dividend ETF, an estimated $636K position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Graypoint LLC opened a new position in Royalty Pharma worth $7.38M.
- Graypoint LLC's largest Q2 2021 buy was Royalty Pharma: 179,916 shares worth $7.38M.
- Graypoint LLC added most to iShares Core MSCI Europe ETF in Q2 2021, an estimated $4.48M increase.
- Graypoint LLC's biggest Q2 2021 reduction was iShares S&P 500 Value ETF, cutting an estimated $105M.
- Graypoint LLC fully exited State Street SPDR Portfolio S&P 500 High Dividend ETF in Q2 2021, selling an estimated $636K.
- Graypoint LLC's ten largest holdings make up 32% of its $753M portfolio in Q2 2021.
- Graypoint LLC opened 29 new positions and closed 3 in Q2 2021.
- Graypoint LLC's portfolio value rose 15% quarter-over-quarter to $753M.
Based on Graypoint LLC's 13F filing for Q2 2021, filed 4 Aug 2021.